BR31: A phase 3, double blind, placebo controlled, randomised trial of adjuvant durvalumab in completely resected non-small cell lung cancer

被引：0

作者：

McLachlan, Sue-Anne ^{[1
,2
]}

Mersiades, Antony ^{[3
]}

Wright, Gavin ^{[4
]}

Millward, Michael ^{[5
]}

Goss, Glenwood ^{[6
]}

Darling, Gail ^{[7
,8
]}

Jurkovic, Hannora ^{[3
]}

Bradley, Ann-Marie ^{[9
]}

Pavlakis, Nick ^{[10
]}

Blinman, Prunella ^{[11
,12
]}

Ding, Keyue ^{[13
]}

O'Callaghan, Chris ^{[9
,14
]}

Stockler, Martin ^{[3
]}

机构：

[1] St Vincents Hosp, Dept Med Oncol, Melbourne, Vic, Australia

[2] Univ Melbourne, Melbourne, Vic, Australia

[3] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia

[4] St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia

[5] Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia

[6] Ottawa Hosp, Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada

[7] Toronto Gen Hosp, Univ Hlth Network, Div Thorac Surg, Dept Surg, Toronto, ON, Canada

[8] Univ Toronto, Toronto, ON, Canada

[9] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada

[10] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia

[11] Concord Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia

[12] Univ Sydney, Sydney, NSW, Australia

[13] Queens Univ, Canc Res Inst, Canadian Canc Trials Grp, Kingston, ON, Canada

[14] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada

来源：

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

419

引用

页码：198 / 199

页数：2

共 50 条

[21] Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer
K Nakagawa
H Tada
A Akashi
T Yasumitsu
K Iuchi
T Taki
K Kodama
British Journal of Cancer, 2006, 95 : 817 - 821
[22] A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan
Ichinose, Yukito
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (Suppl 1) : S43 - S48
[23] A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan
Yukito Ichinose
Cancer Chemotherapy and Pharmacology, 2006, 58 : 43 - 48
[24] A Phase II Study of Adjuvant Chemotherapy with Docetaxel plus Nedaplatin for Completely Resected Non-Small Cell Lung Cancer
Teramoto, K.
Namura, Y.
Hayashi, K.
Ishida, K.
Ueda, K.
Okamoto, K.
Kaku, R.
Hori, T.
Kawaguchi, Y.
Igarashi, T.
Hashimoto, M.
Ohshio, Y.
Kitamura, S.
Motoishi, M.
Suzumura, Y.
Sawai, S.
Hanaoka, J.
Daigo, Y.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1963 - S1964
[25] Adjuvant chemotherapy for resected non-small cell lung cancer
Booth, Christopher M.
Shepherd, Frances A.
JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 180 - 187
[26] Adjuvant Chemotherapy for Resected Non-Small Cell Lung Cancer
Wakelee, Heather
Chhatwani, Laveena
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 198 - 203
[27] Adjuvant therapy in completely resected non-small-cell lung cancer
Giorgio V. Scagliotti
Silvia Novello
Current Oncology Reports, 2003, 5 (4) : 318 - 325
[28] Adjuvant chemotherapy in completely resected non-small-cell lung cancer
Pisters, KMW
Le Chevalier, T
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3270 - 3278
[29] Adjuvant Chemotherapy for Completely Resected Non-Small-Cell Lung Cancer
Suehisa, Hiroshi
Toyooka, Shinichi
ACTA MEDICA OKAYAMA, 2009, 63 (05) : 223 - 230
[30] Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation
Douillard, Jean-Yves
Tribodet, Helene
Aubert, Delphine
Shepherd, Frances A.
Rosell, Rafael
Ding, Keyue
Veillard, Anne-Sophie
Seymour, Lesley
Le Chevalier, Thierry
Spiro, Stephen
Stephens, Richard
Pignon, Jean Pierre
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 220 - 228

← 1 2 3 4 5 →